SSG
DPLO

Summit Securities Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Summit Securities Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-19,100
Closed -$257K – 370
2018
Q4 		$257K Buy
+19,100
New +$322K 0.02% 260

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Summit Securities Group's DPLO Position: Q1 2019 in Review

Summit Securities Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 19,100 shares — an estimated $257K sold.

Summit Securities Group first reported a position in DPLO in Q4 2018 and held it in 1 quarter. The position peaked at $257K in Q4 2018. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • Summit Securities Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • Summit Securities Group sold 19,100 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $257K.
  • Summit Securities Group first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2018 and held it in 1 quarter.
  • Summit Securities Group's DIPLOMAT PHARMACY, INC. position peaked at $257K in Q4 2018.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on Summit Securities Group's 13F filing for Q1 2019, filed 9 May 2019.